alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › secretase-inhibitors

secretase-inhibitors

2 studies tagged secretase-inhibitors, dated 2021-01-02 to 2022-12-28. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies 2022-12-28
  2. Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance 2021-01-02

Studies

2 studies carry this tag.

Date range

2021 to 2022

Top journals

  • Pharmacological research 1
  • The oncologist 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Pharmacological research 2022-12-28 Treatments

    According to the β-amyloid (Aβ) hypothesis of Alzheimer's disease (AD), brain Aβ accumulation is the primary cascade event leading to cognitive deficit and dementia.

  2. Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. The oncologist 2021-01-02 Drug development

    Gamma secretase inhibitors (GSIs), initially developed as Alzheimer's therapies, have been repurposed as anticancer agents given their inhibition of Notch receptor cleavage.

All topic tags with their study counts